BCLS II Equity Opportunities, LP 13D and 13G filings for Atea Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-09-24 5:15 pm Sale | 2021-09-22 | 13D | ATEA PHARMACEUTICALS INC AVIR | BCLS II Equity Opportunities, LP | 3,178,532 3.800% | -846,856 (-21.04%) | Filing |
| 2021-09-03 5:00 pm Sale | 2021-09-01 | 13D | ATEA PHARMACEUTICALS INC AVIR | BCLS II Equity Opportunities, LP | 4,025,388 4.900% | -757,714 (-15.84%) | Filing |